Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function

International Journal of Cardiology

Volumn 175, Issue 2, 2014, Pages 297-306

  Yamazaki, Katrina Go ^a,b   Andreyev, Aleksander Y ^c   Ortiz Vilchis, Pilar ^d   Petrosyan, Susanna ^c   Divakaruni, Ajit S ^c   Wiley, Sandra E ^c   De La Fuente, Christine ^a,b   Perkins, Guy ^e   Ceballos, Guillermo ^c,d   Villarreal, Francisco ^c   Murphy, Anne N ^c  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Medicine ^*  (United States)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^e National Center for Microscopy and Imaging Research   (United States)

Author keywords

Cardiac metabolism; Epicatechin; Mitochondrial pyruvate carrier; Myocardial ischemia reperfusion injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; EPICATECHIN; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; CARDIOTONIC AGENT; CATECHIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; HEART; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRIAL FUNCTION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MYOBLAST; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; HEART MITOCHONDRION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CATECHIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84904254220     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.05.009     Document Type: Article

References (39)

1. A.M. Walters, G.A. Porter, and P.S. Brookes Mitochondria as a drug target in ischemic heart disease and cardiomyopathy Circ Res 111 2012 1222 1236
2. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
3. R. Corti, A.J. Flammer, N.K. Hollenberg, and T.F. Lüscher Cocoa and cardiovascular health Circulation 119 2009 1433 1441
4. A. Buitrago-Lopez, J. Sanderson, and L. Johnson et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis BMJ 343 2011 d4488
5. K.G. Yamazaki, P.R. Taub, and M. Barraza-Hidalgo et al. Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion J Am Coll Cardiol 55 2010 2869 2876
6. K.G. Yamazaki, D. Romero-Perez, and M. Barraza-Hidalgo et al. Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 295 2008 H761 H767
7. P.R. Taub, I. Ramirez-Sanchez, and T.P. Ciaraldi et al. Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa Clin Transl Sci 5 2012 43 47
8. L. Nogueira, I. Ramirez-Sanchez, and G.A. Perkins et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle J Physiol (Lond) 589 2011 4615 4631
9. I. Ramirez-Sanchez, L. Maya, G. Ceballos, and F. Villarreal (-)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways Hypertension 55 2010 1398 1405
10. P.S.M. Prince A biochemical, electrocardiographic, electrophoretic, histopathological and in vitro study on the protective effects of (-)epicatechin in isoproterenol-induced myocardial infarcted rats Eur J Pharmacol 671 2011 95 101
11. D.L. Katz, K. Doughty, and A. Ali Cocoa and chocolate in human health and disease Antioxid Redox Signal 15 2011 2779 2811
12. H. Sies, P.C.H. Hollman, T. Grune, W. Stahl, H.K. Biesalski, and G. Williamson Protection by flavanol-rich foods against vascular dysfunction and oxidative damage 27th Hohenheim Consensus Conference Adv Nutr vol. 3 2012 217 221
13. L. Hooper, C. Kay, and A. Abdelhamid et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials Am J Clin Nutr 95 2012 740 751
14. A.J. Tompkins, L.S. Burwell, S.B. Digerness, C. Zaragoza, W.L. Holman, and P.S. Brookes Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition Biochim Biophys Acta 1762 2006 223 231
15. E.J. Griffiths Mitochondria and heart disease Adv Exp Med Biol 942 2012 249 267
16. S.-J. Ha, and W. Kim Mechanism of ischemia and reperfusion injury to the heart: from the viewpoint of nitric oxide and mitochondria Chonnam Med J 46 2010 129 139
17. D. Morin, T. Hauet, M. Spedding, and J. Tillement Mitochondria as target for antiischemic drugs Adv Drug Deliv Rev 49 2001 151 174
18. H.M. Honda, P. Korge, and J.N. Weiss Mitochondria and ischemia/reperfusion injury Ann N Y Acad Sci 1047 2005 248 258
19. Y. Kushnareva, A.N. Murphy, and A. Andreyev Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P) + oxidation-reduction state Biochem J 368 2002 545 553
20. Y.E. Kushnareva, S.E. Wiley, M.W. Ward, A.Y. Andreyev, and A.N. Murphy Excitotoxic injury to mitochondria isolated from cultured neurons J Biol Chem 280 2005 28894 28902
21. S.E. Wiley, A.Y. Andreyev, and A.S. Divakaruni et al. Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2 + homeostasis EMBO Mol Med 5 2013 904 918
22. S. Miyamoto, A.N. Murphy, and J.H. Brown Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II Cell Death Differ 15 2008 521 529
23. E.J. vGriffiths, and A.P. Halestrap Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts J Mol Cell Cardiol 25 1993 1461 1469
24. Q. Chen, S. Moghaddas, C.L. Hoppel, and E.J. Lesnefsky Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria Am J Physiol Cell Physiol 294 2008 C460 C466
25. G. de Jesús García-Rivas, A. Guerrero-Hernández, G. Guerrero-Serna, J.S. Rodríguez-Zavala, and C. Zazueta Inhibition of the mitochondrial calcium uniporter by the oxo-bridged dinuclear ruthenium amine complex (Ru360) prevents from irreversible injury in postischemic rat heart FEBS J 272 2005 3477 3488
26. M.L. Riess, A.K.S. Camara, Q. Chen, E. Novalija, S.S. Rhodes, and D.F. Stowe Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts Am J Physiol Heart Circ Physiol 283 2002 H53 H60
27. F. Di Lisa, R. Menabò, M. Canton, M. Barile, and P. Bernardi Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD + and is a causative event in the death of myocytes in postischemic reperfusion of the heart J Biol Chem 276 2001 2571 2575
28. G.D. Lopaschuk, C.D.L. Folmes, and W.C. Stanley Cardiac energy metabolism in obesity Circ Res 101 2007 335 347
29. R. Lagoa, I. Graziani, C. Lopez-Sanchez, V. Garcia-Martinez, and C. Gutierrez-Merino Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria Biochim Biophys Acta 2011 1807 1562 1572
30. A.P. Halestrap, and R.M. Denton Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha-cyano-4- hydroxycinnamate Biochem J 138 1974 313 316
31. L.S. Burwell, and P.S. Brookes Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury Antioxid Redox Signal 10 2008 579 599
32. D.K. Bricker, E.B. Taylor, and J.C. Schell et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans Science 337 2012 96 100
33. S. Herzig, E. Raemy, and S. Montessuit et al. Identification and functional expression of the mitochondrial pyruvate carrier Science 337 2012 93 96
34. E.T. Chouchani, C. Methner, and S.M. Nadtochiy et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I Nat Med 19 2013 753 759
35. I. Ramirez-Sanchez, L. Nogueira, and A. Moreno et al. Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise J Cardiovasc Pharmacol 60 2012 429 438
36. S.C. Kolwicz Jr., and R. Tian Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc Med 19 2009 201 207
37. R.T. Mallet, J. Sun, E.M. Knott, A.B. Sharma, and A.H. Olivencia-Yurvati Metabolic cardioprotection by pyruvate: recent progress Exp Biol Med (Maywood) 230 2005 435 443
38. M. Richelle, I. Tavazzi, M. Enslen, and E.A. Offord Plasma kinetics in man of epicatechin from black chocolate Eur J Clin Nutr 53 1999 22 26
39. J.M. Schriewer, C.B. Peek, J. Bass, and P.T. Schumacker ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion J Am Heart Assoc 2 2 2013 e000159